These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27148128)

  • 1. Pharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey.
    Dietz P; Soyka M; Franke AG
    Front Psychol; 2016; 7():520. PubMed ID: 27148128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students.
    Maier LJ; Liechti ME; Herzig F; Schaub MP
    PLoS One; 2013; 8(11):e77967. PubMed ID: 24236008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric Comorbidity and Stress in Medical Students Using Neuroenhancers.
    Jebrini T; Manz K; Koller G; Krause D; Soyka M; Franke AG
    Front Psychiatry; 2021; 12():771126. PubMed ID: 34975573
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological neuroenhancement and the ability to recover from stress - a representative cross-sectional survey among the German population.
    Bagusat C; Kunzler A; Schlecht J; Franke AG; Chmitorz A; Lieb K
    Subst Abuse Treat Prev Policy; 2018 Oct; 13(1):37. PubMed ID: 30348181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Neuroenhancement: teachers' knowledge and attitudes-Results from a survey study among teachers in Germany.
    Franke AG; Lehmberg S; Soyka M
    Subst Abuse Treat Prev Policy; 2016 Sep; 11(1):32. PubMed ID: 27646845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and motives for pharmacological neuroenhancement in Switzerland--results from a national Internet panel.
    Maier LJ; Haug S; Schaub MP
    Addiction; 2016 Feb; 111(2):280-95. PubMed ID: 26189457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroenhancement: State of the Art and Future Perspectives.
    Marazziti D; Avella MT; Ivaldi T; Palermo S; Massa L; Vecchia AD; Basile L; Mucci F
    Clin Neuropsychiatry; 2021 Jun; 18(3):137-169. PubMed ID: 34909030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors.
    Brumboiu I; Porrovecchio A; Peze T; Hurdiel R; Cazacu I; Mogosan C; Ladner J; Tavolacci MP
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33917251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart drugs "as common as coffee": media hype about neuroenhancement.
    Partridge BJ; Bell SK; Lucke JC; Yeates S; Hall WD
    PLoS One; 2011; 6(11):e28416. PubMed ID: 22140584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relevance of pharmacological neuroenhancement for stress and resilience-A multistudy report.
    Darwig J; Gaum PM; Pauli R; Nassri L; Lang J
    Front Public Health; 2022; 10():971308. PubMed ID: 36438304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of substance use for cognitive enhancement by university students in the Netherlands.
    Schelle KJ; Olthof BM; Reintjes W; Bundt C; Gusman-Vermeer J; van Mil AC
    Front Syst Neurosci; 2015; 9():10. PubMed ID: 25741248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.
    Schleim S; Quednow BB
    Front Pharmacol; 2018; 9():3. PubMed ID: 29403383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students.
    Maier LJ; Haug S; Schaub MP
    Drug Alcohol Depend; 2015 Nov; 156():221-227. PubMed ID: 26455555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.
    Franke AG; Northoff R; Hildt E
    Pharmacopsychiatry; 2015 Nov; 48(7):256-64. PubMed ID: 26252723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drugs, alcohol, and illicit substance use and their correlations among medical sciences students in iran.
    Abbasi-Ghahramanloo A; Fotouhi A; Zeraati H; Rahimi-Movaghar A
    Int J High Risk Behav Addict; 2015 Mar; 4(1):e21945. PubMed ID: 25821750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological neuroenhancement and brain doping : Chances and risks].
    Franke AG; Lieb K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):853-9. PubMed ID: 20700786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drug misuse, illicit drug use, and their potential risk and protective correlates in a Hispanic college student sample.
    Cabriales JA; Cooper TV; Taylor T
    Exp Clin Psychopharmacol; 2013 Jun; 21(3):235-44. PubMed ID: 23750694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulant abuse as a coping strategy-Forensic and criminal consequences of stimulant abuse for neuroenhancement.
    Dominik P; Waßmer MP; Soyka M; Franke AG
    Front Public Health; 2022; 10():1028654. PubMed ID: 36388290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons.
    Franke AG; Bagusat C; Dietz P; Hoffmann I; Simon P; Ulrich R; Lieb K
    BMC Med; 2013 Apr; 11():102. PubMed ID: 23570256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "It Was Me on a Good Day": Exploring the Smart Drug Use Phenomenon in England.
    Vargo EJ; Petróczi A
    Front Psychol; 2016; 7():779. PubMed ID: 27303339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.